Not applicableLooking for participantsNCT07302620What this trial is testingHEPARINS: INTERFERENCE IN ARGATROBAN MEASUREMENTWho this might be right forThromboembolic Disease University Hospital, Strasbourg, France 70
Not applicableUnknownNCT04671160What this trial is testingImpact of Continuous Veno-venous Hemodiafiltration on Efficacy of Administration of Prophylactic Doses of Enoxaparin or Fondaparinux in Critically Ill Patients.Who this might be right forAssessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving Anticoagulant Prophylaxis Medical University of Gdansk 80
Post-approval studies (Phase 4)Enrolling By InvitationNCT06862726What this trial is testingApixaban Versus Rivaroxaban in Non Valvular Atrial FibrillationWho this might be right forNon Valvular Atrial Fibrillation Les Laboratoires des Médicaments Stériles 120
Large-scale testing (Phase 3)UnknownNCT04999176What this trial is testingVenous Thromboembolism Prophylaxis After Gynecological Pelvic Cancer Surgery With Rivaroxaban vs EnoxaparinWho this might be right forCancerRivaroxabanVenous Thromboembolism+1 more André Luiz Malavasi Longo de Oliveira 440
Post-approval studies (Phase 4)Study completedNCT01687491What this trial is testingComparison of Anti-Xa Activity of ENOXA ® Versus LOVENOX ® in Acute Coronary SyndromeWho this might be right forAcute Coronary SyndromeFactor X Les Laboratoires des Médicaments Stériles 179
Not applicableUnknownNCT05993533What this trial is testingComparison of the 'CTR' Ratio With Standard Haemostasis Parameters in the Follow-up of Patients Undergoing Heparin TherapyWho this might be right forVenous Thromboembolic Disease Direction Centrale du Service de Santé des Armées 100
Post-approval studies (Phase 4)UnknownNCT02295150What this trial is testingProphylaxis of Venous Thromboembolism After Bariatric SurgeryWho this might be right forMorbid ObesityThromboembolismBypass Complications Rijnstate Hospital 50
Large-scale testing (Phase 3)Study completedNCT00311090What this trial is testingBioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower LimbsWho this might be right forDeep Venous Thrombosis Sanofi 757
Not applicableStudy completedNCT02333929What this trial is testingValidation of Rivaroxaban Assay for US RegistrationWho this might be right forPatients Receiving Rivaroxaban Treatment Diagnostica Stago 100
Large-scale testing (Phase 3)Study completedNCT02746185What this trial is testingCancer Associated Thrombosis, a Pilot Treatment Study Using RivaroxabanWho this might be right forNeoplasmVenous Thromboembolism Assistance Publique - Hôpitaux de Paris 159
Not applicableNot Yet RecruitingNCT07365670What this trial is testingComparison of the Best Method for Measuring Anti-Xa Activity in Children Receiving Unfractionated Heparin in Cardiac Intensive Care (COMPAXE-HNF)Who this might be right forCongenital Heart DiseaseUnfractionated HeparinAnti Xa Activity Centre Hospitalier Universitaire de la Réunion 22
Early research (Phase 1)Study completedNCT02152423What this trial is testingEnoxamed Study in the Treatment of Acute Coronary SyndromesWho this might be right forAcute Coronary Syndrome University of Monastir 50
Not applicableStudy completedNCT01064596What this trial is testingFondaparinux Population Pharmacokinetic to Morbid Obese Patients in Post-operatory Bariatric SurgeryWho this might be right forMorbid ObesityObesitySurgery Centre Hospitalier Universitaire de Saint Etienne 40
Post-approval studies (Phase 4)UnknownNCT03426982What this trial is testingComparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin MonitoringWho this might be right forMyocardial InfarctionVenous ThromboembolismStroke+1 more Wuhan Asia Heart Hospital 700
Not applicableNot Yet RecruitingNCT07559643What this trial is testingThe OAT Trail: The Obesity Anti-Coagulation Thromboprophylaxis Trial.Who this might be right forBariatric SurgeryAnti-Xa ActivityVTE (Venous Thromboembolism)+1 more University College Dublin 180
Not applicableLooking for participantsNCT07183605What this trial is testingComparison of Heparin Anti-Xa Activity From Central Venous Catheter Samples Using a 5 mL Syringe Flush or a Vacuum Tube Flush Versus Peripheral Vein Samples in ICU PatientsWho this might be right forAnticoagulants and Bleeding Disorders Centre Hospitalier Régional d'Orléans 30
Not applicableUnknownNCT02898051What this trial is testingAnti Xa Activity in Cancer Patients Receiving Low-molecular-weight Heparin for Venous ThromboembolismWho this might be right forNeoplasmsVenous Thromboembolism Assistance Publique - Hôpitaux de Paris 370
Not applicableStudy completedNCT02925247What this trial is testingSpecific Anti Factor Xa Activity Dosage to Enhance Detection of Nonadherence in Atrial Fibrillation PatientsWho this might be right forAtrial Fibrillation Assistance Publique Hopitaux De Marseille 150
Not applicableUnknownNCT06431789What this trial is testingProspective Observational Association Between SLCO1B1 Gene Polymorphism and the Anti-factor Xa Activity of Edoxaban in Patients With Moderate to Severe Renal InsufficiencyWho this might be right forGene PolymorphismEdoxabanRenal Insufficiency Yi Han 220
Post-approval studies (Phase 4)Study completedNCT03363035What this trial is testingSafety and Efficacy of LMWH Versus Rivaroxaban in Chinese Patients Hospitalized With Acute Coronary SyndromeWho this might be right forAcute Coronary SyndromeMyocardial InfarctionMyocardial Ischemia+1 more Second Xiangya Hospital of Central South University 2,055